Geron (GERN) updates Clinical Data from GRNOPC1 Spinal Cord Injury Trial – Proactive Investors USA & Canada
Geron (GERN) updates Clinical Data from GRNOPC1 Spinal Cord Injury TrialProactive Investors USA & CanadaThe only side-effects observed were due to the immunosuppressive drug tacrolimus, which is administered for the first two months after injection of …